Ivan Fuss

Ivan Fuss

Auto-generated profile, based on publicly available information

Ivan Fuss

Staff Clinician/NIH

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2018 in Science Translational Medicine
Verified
Journal Article
Open access
PDF file
TTTetsuya Takagawa
Tetsuya Takagawa
AKAtsushi Kitani
Atsushi Kitani
IFIvan Fuss
Ivan Fuss
BLBeth Levine
Beth Levine
SBSteven R. Brant
Steven R. Brant
WSWarren Strober
Warren Strober
The LRRK2/MUC19 gene region constitutes a high-risk genetic locus for the occurrence of both inflammatory bowel diseases (IBDs) and Parkinson’s disease. We show that dendritic cells (DCs) from patients with Crohn’s disease (CD) and lymphoblastoid cell lines derived from patients without CD but bearing a high-risk allele (rs11564258) at this locus as heterozygotes exhibited increased LRRK2 expression in vitro. To investigate the immunological consequences of this increased LRRK2 expression, we conducted studies in transgenic mice overexpressing Lrrk2 and showed that these mice exhibited more severe colitis induced by dextran sodium sulfate (DSS) than did littermate control animals. This increase in colitis severity was associated with lamina propria DCs that showed increased Dectin-1–induced NF-κB activation and proinflammatory cytokine secretion. Colitis severity was driven by LRRK2 activation of NF-κB pathway components including the TAK1 complex and TRAF6. Next, we found that membrane-associated LRRK2 (in association with TAB2) caused inactivation of Beclin-1 and inhibition of autophagy. HCT116 colon epithelial cells lacking Beclin-1 exhibited increased LRRK2 expression compared to wild-type cells, suggesting that inhibition of autophagy potentially could augment LRRK2 proinflammatory signaling. We then showed that LRRK2 inhibitors decreased Dectin-1–induced TNF-α production by mouse DCs and ameliorated DSS-induced colitis, both in control and Lrrk2 transgenic animals. Finally, we demonstrated that LRRK2 inhibitors blocked TNF-α production by cultured DCs from patients with CD. Our findings suggest that normalization of LRRK2 activation could be a therapeutic approach for treating IBD, regardless of whether a LRRK2 risk allele is involved.

1 October 1996 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MNMarkus F. Neurath
Markus F. Neurath
IFIvan Fuss
Ivan Fuss
BKBrian Kelsall
Brian Kelsall
KBK.-H. Meyer Zum Büschenfelde
K.-H. Meyer Zum Büschenfelde
WSWarren Strober
Warren Strober

1 January 2017 in Oncology Reports
Verified
Journal Article
Open access
PDF file
JMJunko Masuda
Junko Masuda
ETEiji Takayama
Eiji Takayama
WSWarren Strober
Warren Strober
ASAyano Satoh
Ayano Satoh
Yuji MorimotoYuji Morimoto
Yuji Morimoto
MSMasaharu Seno
Masaharu Seno
To evaluate systemic immunity associated with tumor growth limited to a subcutaneous site versus growth proceeding at multiple tumor sites, we established syngeneic mouse subcutaneous and pulmonary tumor models by local subcutaneous and intravenous injection of colon carcinoma CT26 cells. We found that splenic myeloid-derived suppressor cell (MDSC) levels were significantly increased in the subcutaneous tumor model but not in the pulmonary tumor model. Furthermore, both CD4+ and CD8+ T cells as well as CD4+ Foxp3+ T cells were significantly decreased in the subcutaneous tumor model and were largely unchanged in the pulmonary tumor model. In addition, the subcutaneous model, but not the pulmonary model, displayed a Th1 polarization bias. This bias was characterized by decreased IL-4, IL-9, and IL-10 production, whereas the pulmonary model displayed increased production of IL-10. These results suggest that the mode of tumor development has differential effects on systemic immunity that may, in turn, influence approaches to treatment of cancer patients.

1 December 2004 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
AKArthur Kaser
Arthur Kaser
ENEdward E. S. Nieuwenhuis
Edward E. S. Nieuwenhuis
WSWarren Strober
Warren Strober
LMLloyd Mayer
Lloyd Mayer
IFIvan Fuss
Ivan Fuss
RBRichard S. Blumberg
Richard S. Blumberg

23 November 2012
Verified
Book Chapter
Closed access
PDF file
EZEdwin de Zoeten
Edwin de Zoeten
IFIvan J. Fuss
Ivan J. Fuss

30 April 2003 in Gastroenterology
Verified
Journal Article
Closed access
KNKazuhiko Nakamura
Kazuhiko Nakamura
AKAtsushi Kitani
Atsushi Kitani
IFIvan Fuss
Ivan Fuss
MTMakoto Takahashi
Makoto Takahashi
KHKuniomi Honda
Kuniomi Honda
WSWarren Strober
Warren Strober